Cioffi Melina
SEC insider (Form 3/4/5 filer). CIK 0002066841. SVP, Regulatory Affairs at Aquestive Therapeutics, Inc. (AQST). 5 reported Form 4/5 transactions since Sep 2024; latest on May 15, 2026. Located in WARREN, NJ.
Companies Cioffi Melina has filed insider reports for
- Aquestive Therapeutics, Inc. (AQST): Officer, SVP, Regulatory Affairs
Cioffi Melina
CIK: 0002066841
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (20.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (40.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (40.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AQST
Aquestive Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- May 15, 2026AQST
Aquestive Therapeutics, Inc.
Tax PaymentDirect1.7K shares at avg. $4.17$7K - Mar 10, 2026AQST
Aquestive Therapeutics, Inc.
SaleDirect25.3K shares at avg. $4.17$106K - Mar 9, 2026AQST
Aquestive Therapeutics, Inc.
AwardDirect100K shares- - Dec 2, 2025AQST
Aquestive Therapeutics, Inc.
Tax PaymentDirect2.1K shares at avg. $5.93$12K - May 15, 2025AQST
Aquestive Therapeutics, Inc.
AwardDirect20K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 15, 2026 | AQST Aquestive Therapeutics, Inc. | Tax Payment | 1,667 | $4.17 | $6,951 | Direct |
| Mar 10, 2026 | AQST Aquestive Therapeutics, Inc. | Sale | 25,311 | $4.17 | $105,623 | Direct |
| Mar 9, 2026 | AQST Aquestive Therapeutics, Inc. | Award | 100,000 | - | $0 | Direct |
| Dec 2, 2025 | AQST Aquestive Therapeutics, Inc. | Tax Payment | 2,083 | $5.93 | $12,352 | Direct |
| May 15, 2025 | AQST Aquestive Therapeutics, Inc. | Award | 20,000 | - | - | Direct |
1-5 of 5 transactions